Regeneron Pharmaceuticals Inc. stock underperforms Monday when compared to competitors
This was the stock's fourth consecutive day of losses.
Hosted on MSN57m
Regeneron Gets Positive CHMP Opinion for Multiple Myeloma Drug
Regeneron Pharmaceuticals, Inc. REGN obtained positive opinion for its pipeline candidate linvoseltamab from the European ...